LINEAGE CELL THERAPEUTICS IN's ticker is and the CUSIP is 53566P959. A total of 3 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,820 | -6.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3,000 | -25.0% | 2,000 | -16.7% | 0.00% | – |
| Q1 2022 | $4,000 | -89.5% | 2,400 | -84.6% | 0.00% | – |
| Q4 2021 | $38,000 | +171.4% | 15,600 | +188.9% | 0.00% | – |
| Q3 2021 | $14,000 | +27.3% | 5,400 | +42.1% | 0.00% | – |
| Q2 2021 | $11,000 | -45.0% | 3,800 | -55.8% | 0.00% | – |
| Q1 2021 | $20,000 | +300.0% | 8,600 | +207.1% | 0.00% | – |
| Q4 2020 | $5,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 8,600 | $20,000 | 0.00% |
| SIMPLEX TRADING, LLC | 733 | $172,000 | 0.00% |